Secondary prevention of cardiovascular disease: is it time for the polypill to be standard treatment?

Secondary prevention of cardiovascular disease: is it time for the polypill to be standard treatment?

Saved in:

Bibliographic Details
Main Author:	Tom Marshall
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	The Lancet Regional Health. Europe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776225001760
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
by: Николай Владимирович Абрамов, et al.
Published: (2024-02-01)

Relevance of Polypill for Primary Prevention of Cardiovascular Diseases in the 21st Century
by: Rajeev Gupta
Published: (2025-06-01)

Efficacy of different polypill combinations for primary and secondary cardiovascular disease prevention: a systematic review and meta-analysis
by: Habib Yazgi, et al.
Published: (2025-06-01)

Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context
by: Thomas Gaziano, et al.
Published: (2025-08-01)

Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial
by: Fred Stephen Sarfo, et al.
Published: (2024-08-01)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
by: Sue Jowett, et al.
Published: (2017-01-01)

Effective polypill therapy in patients with hypertension and dyslipidemia
by: V. E. Oleynikov, et al.
Published: (2025-07-01)

The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?
by: Sajjad Biglari, et al.
Published: (2025-06-01)

Reducing premature mortality from cardiovascular diseases in low and middle income countries: The role of Polypill in public health policy
by: Sadaf G. Sepanlou, et al.
Published: (2025-06-01)

Is It Time for Polypill in Heart Failure Therapy? Current Preference among Indian Cardiologists: A Cross-sectional Survey
by: Kamal Sharma, et al.
Published: (2025-01-01)

Development of Amlodipine Mini-tablets as a Polypill-component for the Personalized Therapy of Arterial Hypertension
by: K. M. Tserkovnaya, et al.
Published: (2023-12-01)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
by: Aarti Thakkar, et al.
Published: (2021-11-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

ASPIRIN AS A “GOLD STANDARD” IN CARDIOVASCULAR PREVENTION
by: S. V. Nedogoda
Published: (2010-06-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease
by: article Editorial
Published: (2023-12-01)

Chinese Guideline on the Primary Prevention of Cardiovascular Diseases: Time to Start Better Cardiovascular Primary Prevention
by: Guang Ning, et al.
Published: (2021-06-01)

Secondary cardiovascular prevention: cardioprotective pharmaceutical therapy
by: article Editorial
Published: (2011-12-01)

Mechanochemical‐Induced Swelling–Activation of a Gastric‐Deployable 4D‐Printed Polypill Inspired by Natural Hygromorphic Actuators
by: Konstantina Chachlioutaki, et al.
Published: (2025-04-01)

Finding the right dose of acetylsalicylic acid for secondary prevention of atherosclerotic cardiovascular disease
by: André Garcia, et al.
Published: (2025-07-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Nutraceutical support in the prevention and treatment of cardiovascular diseases
by: E. V. Gracheva, et al.
Published: (2023-07-01)

Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
by: A.V. Fonyakin, et al.
Published: (2014-05-01)

EDUCATIONAL INTERVENTION FOR THE CARDIOVASCULAR PREVENTION IN ADOLESCENTS OF SECONDARY BASIC.
by: Yuri Arnold Domínguez
Published: (2011-08-01)

An update on the measurement and management of cholesterol with specific reference to secondary prevention of cardiovascular disease (CVD)
by: Muhammed Vally, et al.
Published: (2018-03-01)

EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY
by: E. A. Ushkalova, et al.
Published: (2016-06-01)

Effects of a cardioprotective nutritional program on apolipoproteins and lipids in secondary cardiovascular disease prevention
by: Aline Marcadenti, et al.
Published: (2025-03-01)

Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01)

Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment
by: James B. Young, et al.
Published: (2022-12-01)

STATIN ROLE IN CARDIOVASCULAR DISEASE PREVENTION AND TREATMENT (AN EXAMPLE OF SIMVASTATIN)
by: M. A. Gurevich
Published: (2010-04-01)

New concept of cardiovascular disease prevention: combined treatment role
by: article Editorial
Published: (1970-01-01)

A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Mohamad B. Taha, et al.
Published: (2021-09-01)

Testing the educational program “Primary and secondary prevention of cardiovascular diseases” on the basis of social networking service Instagram
by: A. E. Demkina, et al.
Published: (2020-09-01)

Innovations in cardiovascular sciences – A roadmap toward new standardization in cardiovascular treatment
by: N N Khanna
Published: (2022-01-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Urgent prevention in cardiovascular disease
by: V. V. Ruksin
Published: (2005-04-01)

Cellular and Molecular Bases for the Application of Polyphenols in the Prevention and Treatment of Cardiovascular Disease
by: Carlo Caiati, et al.
Published: (2025-07-01)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015-09-01)

Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
by: I. E. Chazova, et al.
Published: (2022-10-01)